ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,339, issued on Nov. 18, was assigned to Zealand Pharma A/S (Soborg, Denmark).
"Acylated glucagon analogues" was invented by Ditte Riber (Bronshoj, Denmark), Jakob Lind Tolborg (Herlev, Denmark), Dieter Wolfgang Hamprecht (Pozzolengo, Italy) and Wolfgang Rist (Ingelheim am Rhein, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel acylated glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity ...